• CLSI QMS12-A

CLSI QMS12-A

Development and Use of Quality Indicators for Process Improvement and Monitoring of Laboratory Quality; Approved Guideline, QMS12AE

Clinical and Laboratory Standards Institute, 12/01/2010

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/12/2010

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

Clinical and Laboratory Standards Institute document GP35-A--Development and Use of Quality Indicators for Process Improvement and Monitoring of Laboratory Quality; Approved Guideline provides guidance on development of quality indicators and their use in the medical laboratory. These indicators include measures developed in a single laboratory for local use and indicators developed by other organizations and national bodies. The document includes criteria for development of quantitative, ordinal, and qualitative indicators; it also includes procedures for gathering data, presenting and interpreting results, monitoring performance over time, and comparing performance with other laboratories or national norms.

More CLSI standard pdf

CLSI M31S1

CLSI M31S1

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement, M31-S1

$90.00 $180.00

CLSI I/LA23-A

CLSI I/LA23-A

Immunoassay Systems: Radioimmunoassays and Enzyme, Fluorescence, and Luminescence Immunoassays; Approved Guideline, ILA23AE

$148.00 $297.72

CLSI M36-A

CLSI M36-A

Clinical Use and Interpretation of Serologic Tests for Toxoplasma gondii; Approved Guideline, M36AE

$132.00 $264.43

CLSI M33-A

CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

$120.00 $240.30